During Thursday’s trading session, the shares of a global pharmaceutical company providing access to affordable and innovative medicines tumbled by nearly 2 percent on BSE, after CITI Research trimmed target price and recommended a “sell” rating on the...
Pharma stocks dropped on Monday morning after the Delhi High Court, on Friday, barred several companies from selling semaglutide in India. The order followed a patent infringement case filed by Novo Nordisk, prompting concerns in the market and impacting shares of...
Indian pharmaceutical companies with substantial exposure to the US witnessed a surge of up to 14 percent on today’s trading session, after US President Donald Trump exempted pharmaceutical products from reciprocal tariffs in the sector. The Nifty Pharma index jumped...
India’s CDMO (Contract Development and Manufacturing Organization) market is projected to grow from $15.63 billion in 2023 to $44.63 billion by 2029. This rapid growth is driven by cost advantages, technological advancements, and a strong regulatory framework. ...
Foreign portfolio inflows into Indian equities have been negative since the beginning of 2025. As of mid-February, Foreign Institutional Investors (FIIs) have net sold Indian equities worth Rs 33,527.55 crores. Between February 1 and February 15, their net sales...
Shares of this small-cap pharmaceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs) surged xx percent on launching the first and only oncology drug approved for neck and head cancer in India first...
Search Topic or Keyword
Easiest Stock Screener Tool!
Best stock discovery tool with +130 filters, built for fundamental analysis. Profitability, Growth, Valuation, Liquidity, and many more filters. Search Stocks Industry-wise, Export Data For Offline Analysis, Customizable Filters.
